Clinical Trials Browser

Withdrawn × Resectable Pancreatic Cancer × Gemcitabine × Clear all

NCT03392571 2019-05-07

Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients

Phase 2 Withdrawn

Gastrointestinal

Resectable Pancreatic Cancer